Type I interferons and herpes simplex virus infection: a naked DNA approach as a therapeutic option?
Herpes simplex virus (HSV) types 1 and 2 are highly successful human pathogens that can elicit blinding herpetic keratoconjunctivitis, fatal sporadic encephalitis, aseptic meningitis, and increase the risk of acquiring additional sexually transmitted diseases. Type I interferons (IFN) play a significant role in controlling HSV pathogenesis by antagonizing viral replication and spread. Taking advantage of the susceptibility of HSV to IFNs, a novel approach of employing plasmid DNA cassettes expressing type 1 IFNs to antagonize viral pathogenesis has been undertaken. This review will describe recent work in our lab and those of others using naked DNA encoding cytokines to antagonize HSV replication and virus trafficking or immune-mediated pathogenesis as a result of viral assault to ocular tissue.
Noisakran
S
S
Department of Ophthalmology, Microbiology, and Immunology, The University of Oklahoma Health Sciences Center, Oklahoma City, USA.
Carr
D J
DJ
D000818:Animals; D005128:Eye Diseases / Q000276:immunology* / Q000473:pathology / Q000628:therapy; D015316:Genetic Therapy / Q000379:methods; D006561:Herpes Simplex / Q000276:immunology* / Q000473:pathology / Q000628:therapy; D018259:Herpesvirus 1, Human / Q000254:growth & development / Q000276:immunology*; D016898:Interferon-alpha / Q000235:genetics / Q000276:immunology*; D051379:Mice; D010957:Plasmids / Q000276:immunology; D019076:Transgenes / Q000276:immunology; D019444:Vaccines, DNA / Q000276:immunology* / Q000592:standards; D014765:Viral Vaccines / Q000276:immunology*
D016898:Interferon-alpha; D019444:Vaccines, DNA; D014765:Viral Vaccines